Mortality Risks Up for Women With Adverse Pregnancy Outcomes
By Elana Gotkine HealthDay Reporter
WEDNESDAY, April 17, 2024 -- Women who experience any of five major adverse pregnancy outcomes have increased mortality risks, which remain elevated during long-term follow-up, according to a study published online April 15 in JAMA Internal Medicine.
Casey Crump, M.D., Ph.D., from the University of Texas Health Science Center in Houston, and colleagues examined long-term mortality risks associated with five major adverse pregnancy outcomes in a national cohort study in Sweden. The study included 2,195,667 women with a singleton delivery during 1973 to 2015 with information on pregnancy duration and infant birth weight.
The researchers found that 4 percent of the women died during 56 million person-years of follow-up. Independent associations were seen for all five adverse pregnancy outcomes with increased mortality. Adjusted hazard ratios for all-cause mortality associated with specific adverse pregnancy outcomes were 1.52, 1.41, 1.30, 1.27, and 1.13 for gestational diabetes, preterm delivery, small for gestational age, other hypertensive disorders, and preeclampsia, respectively, across the entire follow-up. After adjustment for shared familial factors in cosibling analyses, these effect sizes were only partially reduced (0 to 45 percent). Further increases in risk were seen for women who experienced multiple adverse pregnancy outcomes.
"Women with adverse pregnancy outcomes need early preventive actions and long-term follow-up for timely detection and treatment of chronic disorders associated with early mortality," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States
THURSDAY, Oct. 31, 2024 -- Early-onset colorectal cancer (EO-CRC) mortality rose in the United States over the past two decades, most notably in patients aged 20 to 44 years...
Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening
WEDNESDAY, Oct. 30, 2024 -- Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other screening modalities...
American College of Surgeons, Oct. 19-22
The annual meeting of the American College of Surgeons was held this year from Oct. 19 to 22 in San Francisco and attracted participants from around the world, including...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.